Premium
Letter: should colectomy be the end‐point to evaluate the effectiveness of drug therapies in severe ulcerative colitis? Authors' reply
Author(s) -
Katsuno T.,
Saito K.,
Yokosuka O.
Publication year - 2013
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.12139
Subject(s) - medicine , ulcerative colitis , infliximab , ciclosporin , colectomy , guideline , refractory (planetary science) , golimumab , surgery , intensive care medicine , transplantation , disease , physics , pathology , astrobiology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom